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The impact of multimorbidity on foot
health outcomes in podiatry patients with
musculoskeletal foot pain: a prospective
observational study
Gordon J. Hendry1* , Linda Fenocchi1,2, Helen Mason2 and Martijn Steultjens1
Abstract
Background: Multimorbidity is prevalent and adversely affects health outcomes. Foot pain is common and one of
the primary reasons for utilisation of podiatry services. At present, little is known about the impact of multimorbidity on
foot health and related outcomes following podiatric intervention. The aims of this study were to evaluate whether
there is a difference in foot health outcomes following exposure to podiatric foot care for people with and without
multimorbidity; and ii) to evaluate whether the presence or absence of multimorbidity affects patients’ perceptions of
change in foot pain.
Methods: The PROMFoot study is a prospective cohort study of adults with a new episode of foot pain attending the
podiatry service within the NHS Greater Glasgow and Clyde health board. Baseline medical comorbidity status (no
condition, single condition, multiple conditions), longitudinal data on foot health measured using the Foot Health
Status Questionnaire (FHSQ), and patient rating of change scores for foot pain were obtained from the PROMFoot
study at baseline, and 3 and 6months after podiatric intervention. Foot health scores (pain, function, footwear and
general foot health) and perceptions of change for foot pain were compared between comorbidity groups.
Results: A total of 115 participants (59% female) with a mean age of 55 years were included. Multimorbidity was
common, affecting 61 participants (53%); while 28 (24.3%) and 26 (22.6%) reported single or no medical comorbidities
respectively. Significantly worse foot health scores for all FHSQ domains were observed for the multimorbidity group at
baseline, 3 and 6months. Change scores for foot pain were similar between groups and demonstrate modest
improvements, however multimorbidity group membership was strongly associated with a perceptions of change in
foot pain. Multimorbidity was independently associated with poorer foot function outcomes at 3 months, and poorer
foot pain and foot function outcomes at 6 months.
Conclusions: Multimorbidity was associated with poor foot health outcomes and lower rates of self-perceived
improvement in foot pain over 6 months following podiatric intervention in a sample of patients attending podiatric
biomechanics clinics for a new episode of foot pain.
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Background
Foot pain is reported as common in the general popula-
tion with prevalence estimates ranging from 17 to 30%
[1]. Recent research suggests that multimorbidity may be
an important correlate of foot pain [2], and the presence
of multiple chronic diseases has been identified as a strong
predictor of podiatry service utilisation [3]. Multimorbid-
ity, defined as the co-existence of two or more medical
conditions is a major national and international health
concern [4]. It affects 25% of the Scottish population [4]
and approximately 50 million people in the European
Union, and its prevalence is rising [5, 6]. Multimorbidity is
strongly associated with increasing age, with a Scottish
prevalence of 65% in those aged 65–84, increasing to 82%
in those aged 85 or over [4]. It is also strongly associated
with social deprivation, and occurs on average around 10–
15 years earlier in the most deprived compared to the least
deprived areas [4]. People with multimorbidity tend to
have a lower quality of life and poorer health outcomes
than people with a single condition [7]. It is a major cause
of work disability and is a significant burden on the health
service due to patients’ complex and long-term care needs
[6, 8]. Patients with multimorbidity are also particularly
vulnerable to treatment burden, where poor health and
disease symptoms impact on their ability to attend health-
care appointments, adhere to medical and non-medical
management regimes, and undertake physical activity [6].
Patterns of diseases in multimorbidity can be highly
variable as it can occur due to simple co-occurrence by
chance, exposure to shared risk factors, and/or a patho-
genic link between conditions [6]. For example, risk fac-
tors for musculoskeletal (MSK) disorders such as obesity
are often shared with other prevalent chronic long-term
conditions such as type 2 diabetes [6, 9]. Further, patho-
genic links have been identified between MSK disorders
such as inflammatory joint diseases and cardiovascular
disease [6, 10]. Along with cardiovascular diseases and
mental health problems, MSK disorders represent a
major multimorbidity cluster [11]. For these reasons,
MSK disorders are a major feature of multimorbidity.
At present, little is known about the impact of multi-
morbidity on foot health and related outcomes following
podiatric intervention. For MSK foot pain, the current lit-
erature is dominated by studies which focus on single dis-
eases (such as rheumatoid arthritis) or non-disease-
specific risk factors (such as age, gender and/or obesity)
and their associations with foot health outcomes such as
foot pain and/or function [12, 13]. With regards to podia-
try, the majority of podiatric foot care, research and edu-
cation largely conforms to a single-disease framework
which may be suboptimal given the rapidly increasing
prevalence of multimorbidity. At present, it is unclear
how multimorbidity impacts on foot health and outcomes
following exposure to podiatric interventions.
Accordingly, the aims of this exploratory study were to i)
evaluate whether there is a difference in foot health out-
comes following exposure to podiatric foot care for people
with and without multimorbidity; and ii) to evaluate
whether the presence or absence of multimorbidity affects
patients’ perceptions of change in foot pain.
Methods
Participants and setting
Participants in this study are from the Patient Reported
Outcome Measures Foot (PROMfoot) Study. In short,
PROMfoot is a longitudinal observational cohort study
that was designed to evaluate measurement properties of
four different foot-specific and generic patient reported
outcome measures (PROMs) including the Foot Health
Status Questionnaire (FHSQ), the Foot Function Index,
the EuroQoL 5-dimensional questionnaire (EQ5D-5 L),
and the Short-form 6-dimension questionnaire. The
PROMfoot study was conducted within the National
Health Service (NHS) Greater Glasgow and Clyde
(GG&C) Health Board region. Patients with a new episode
of foot pain who were referred to NHS GG&C Podiatric
Biomechanics Clinics were the target population. Referrals
to NHS GG&C Podiatric Biomechanics Clinics are largely
comprised of patients with complex musculoskeletal foot
pathology. Patients are allocated at the discretion of the
podiatrist responsible following vetting of written referrals
from general practice, orthopaedics, other health profes-
sions, or internal escalation following initial podiatry treat-
ment. Patients were eligible to participate if they i) were
scheduled to attend as a new patient for treatment at a po-
diatric biomechanics clinic within NHS GG&C; ii) self-
reported current foot pain; iii) were aged 18 years or more;
and iv) were willing and able to provide written informed
consent. Patients were not eligible to participate if they
failed to meet any of the above inclusion criteria. Ethical
approval was obtained from the South East Scotland NHS
Research Ethics Committee (16/SS/0193) on 2nd Novem-
ber 2016. Recruitment was undertaken between January
and December 2017. For the purposes of addressing the
aims of this study, longitudinal FHSQ data from PROM-
foot are reported.
Recruitment
Potentially eligible participants were identified by screen-
ing NHS GG&C Podiatric Biomechanics clinic lists using
the TrakCare electronic patient management system by an
NHS GG&C Podiatrist. Potentially eligible participants
were sent an invitation letter and a study participant infor-
mation sheet, and willing participants were invited to con-
tact the researcher (LF). Telephone-based screening was
undertaken to confirm study eligibility and patients’ will-
ingness to participate. Patients who were willing to take
part were invited to return signed consent forms to the
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researcher to confirm their participation in the study and
complete baseline assessments via completion of a postal
or web-based survey, according to their personal prefer-
ence. Enrolment was confirmed upon receipt of written
consent and completed baseline data.
Data collection baseline
Study data were collected and managed primarily using
the Research Electronic Data Capture (REDCap) secure
electronic data capture tool hosted at Glasgow Caledo-
nian University [14]. Study data obtained using paper
based forms and returned via mail were manually en-
tered into the REDCap database by the researcher.
Baseline demographic data collected included age
(years), sex, employment status (full-time, part-time, vol-
untary, looking for work, student, looking after home/
family, wholly retired, permanently unable to work, other,
prefer not to answer), and self-reported height and weight
for calculation of body mass index (BMI). Participants’
post codes were collected in order to calculate indices of
social deprivation [15–17]. These were expressed as lowest
2 quintiles (most deprived) versus upper 3 quintiles (least
deprived). Self-reported health-related quality of life
(HRQoL) was measured as a baseline descriptor of health
status and evaluated using the Euro quality of life (Euro-
qol) five dimension 5 level questionnaire (EQ-5D-5 L) and
100mm visual analogue scale (EQ-VAS) (higher scores in-
dicating better health) [18]. Medical conditions/comorbid-
ities were evaluated using the Self-Administered
Comorbidity Questionnaire (SCQ), a valid and reliable
questionnaire which requires no prior medical knowledge
for the self-report of comorbidity [19]. The SCQ scores
the presence or absence of comorbid conditions, whether
or not the participant receives treatment for the condi-
tion(s), and whether the condition(s) limits activities [19].
For the purpose of this study, multimorbidity was defined
as the coexistence of two or more chronic conditions [20].
In order to address the impact of multimorbidity on pri-
mary and secondary outcome variables, the presence or
absence of single medical conditions or multimorbidity
was calculated using baseline SCQ responses to create 3
groups; 1) no conditions (n = 0 conditions), 2) single con-
dition (n = 1 condition), and 3) multimorbidity (> 1 condi-
tion). Foot pain severity experienced during the previous
week was measured as a baseline descriptor using a nu-
merical rating scale (NRS) from 0 to 10 (0 no pain, 10
worst pain possible). Regional foot pain location (hindfoot,
forefoot, toes, ball, arch, heel, nails) was evaluated using a
foot pain map developed previously and widely used for
epidemiological research [21].
Primary and secondary outcomes
The primary outcome of interest was foot health at 3
and 6month follow-ups, which was evaluated using the
Foot Health Status Questionnaire (FHSQ), a valid and
reliable 13-item questionnaire with four domains includ-
ing pain, function, footwear, and general foot health [22,
23]. The FHSQ is completed using a 5-point Likert scale,
and scored by transforming to a scale ranging from 0
(poorest foot health) to 100 (best foot health) [22, 24].
The secondary outcome of interest was participants’ per-
ceptions of change in foot pain, measured using a 7-
point patient rating of change scale (PRCS) for foot pain
(very much worse to very much improved) [25] from
baseline to 3 and 6month follow-ups respectively.
Follow-up data collection
Follow-up study data were captured at 3 and 6months
after baseline measurements. Three and 6-month data
included the 4 domains of the FHSQ and the 7-point
PRCS. Podiatric foot care treatments received and self-
care undertaken over the 6-month study period were re-
corded for each participant using a standard check-box
list (foot orthoses, footwear advice/modifications, medi-
cations, rest, exercises, physical therapies, and acupunc-
ture) and free text box for other treatments.
Statistical analyses
Demographic and general health characteristics were
summarized using descriptive statistics. Continuous data
were screened for normality of distributions using the
Kolmogorov-Smirnov test. Continuous variables were
summarised using means and standard deviations (SD),
and medians and inter-quartile ranges (IQR) where ap-
propriate. For categorical and ordinal data, proportions
were calculated and expressed as absolute frequencies
(n) and percentages (%). Ordinal data from the PRCS
were dichotomised and recoded as a categorical variable
(improvement versus no change/deterioration). Differ-
ences in demographic and general health characteristics
between groups were evaluated using Kruskal-Wallis
and Mann-Whitney post hoc tests where appropriate.
Differences between groups for discrete FHSQ domain
scores at baseline, 3 and 6months, and change scores
between baseline, 3 and 6months were evaluated using
Kruskal-Wallis tests and Mann-Whitney post hoc tests
where appropriate. To identify associations between
multimorbidity status and participants’ self-perception of
change in foot pain (dichotomised PRCS), Pearson’s chi-
square tests were performed and presented as 3 × 2 con-
tingency tables. Chi square test effect sizes were calcu-
lated using Cramer’s V. Multivariate linear regression
analyses were undertaken to identify associations be-
tween multimorbidity status and FHSQ domain scores
at 3 and 6months with and without adjustment for co-
variates. All tests were two-tailed and p values < 0.05
were considered to indicate statistical significance. All
analyses were undertaken using IBM® SPSS® version 25.
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Given the prospective nature of the study, some loss to
follow-up was anticipated. Missing data were accounted
for using 3 approaches. Secondary missing data analyses
included 1) comparison of baseline demographic charac-
teristics between the complete (referred to as closed co-
hort) and incomplete cohorts (open cohort); 2) graphical
explorations of primary outcome data at discrete time
points and change scores over time for closed and open
cohorts; and 3) sensitivity analyses with repetition of pri-
mary and secondary outcome data analyses for the closed
cohort (see Additional files 1, 2, 3, 4, 5, 6 and 7). The pri-
mary method of analysis was open cohort with no imput-
ation of missing data, supplemented with secondary
missing data analyses provided above to aid interpretation.
Results
Study population
Of the 1329 invitations sent, 193 individuals responded
(14.5%). Of these, 154 (79.8%) were eligible, and of these
115 (74.7%) were enrolled (Fig. 1). Of the 115 partici-
pants, 59% were female and the mean (SD) age was 55
(11.6) years. At least partial FHSQ data (defined as com-
pletion of at least 1 FHSQ domain) was available for 115
participants at baseline, reducing to 91 (79%) at 3
months, and 82 (71%) at 6-month follow-up. A total of
62 participants (54%) had complete baseline, 3 and 6
months’ follow-up data for all FHSQ domains.
Participant demographic characteristics and baseline
clinical characteristics are summarised in Tables 1, 2 and 3.
The sample was typically overweight or obese, with a me-
dian (IQE) BMI of 29.9 (19.2); in a state of suboptimal
HRQoL; and approximately 42% were classified in the
lower 2 quintiles (most deprived) of social deprivation. Ap-
proximately half of participants were in paid full-time or
part time employment (48.7%), whilst over one-third
(34.8%) were either wholly retired or permanently unable
to work.
Twenty-six participants (22.6%) reported having no med-
ical condition, while 28 (24.3%) and 61 (53%) reported hav-
ing a single or multiple conditions respectively (Table 2).
The median (range) for total number of conditions per par-
ticipant was 2 (0–11). Back pain was the most common co-
morbid medical condition reported by participants (43.5%),
followed by osteoarthritis (33.0%), high blood pressure
(20.0%), depression (17.4), ulcer/stomach disease (11.3%)
and heart disease (10.4%). Of the comorbid medical condi-
tions with a sample point prevalence at baseline greater
than 10%, osteoarthritis was the condition which propor-
tionally resulted in limitation of activities for most partici-
pants (32/38, 84.2%), followed by depression (15/20, 75.0%),
back pain (34/50, 68.0%), heart disease (6/12, 50%), ulcer/
stomach disease (6/13, 46.2%) and high blood pressure (6/
23, 26.1%). Moderate proportions of participants with
osteoarthritis (36.8%), back pain (66%) and/or depression
(45%) were not receiving treatment for their condition.
At study baseline, all participants presented with foot
pain and this ranged generally from moderate to severe,
with a median (IQR) of 6/10 (4) (Table 3). Foot pain was
common, with between 42.6–53% of participants report-
ing pain affecting the heel, hindfoot, arch, ball, toes, and
forefoot regions. Pain at the nails was less frequently re-
ported (10.4%). Median (IQR) values for foot health at
baseline suggest that all FHSQ domains were significantly
impaired including FHSQ pain (35, 16.86–60.0), function
(62.5, 25.0–81.25), footwear (33.33, 16.67–58.33) and gen-
eral foot health (25.0 0–60.0).
Morbidity group demographic and clinical characteristics
Median age and BMI were higher in the group with
multiple medical conditions compared to no conditions
(age p = 0.099 not significant (NS), BMI p = 0.041) and
single condition group (age p = 0.111 NS, BMI p = 0.084,
NS) (Table 1). Participants in the multiple conditions
group reported lower EQ-5D-5 L Index and VAS scores
than no conditions (p < 0.001, p = 0.001) and single con-
ditions groups (p < 0.001, p = 0.004) (Table 1). Absolute
and relative frequencies suggest lower rates of paid full-
time employment, higher rates of social deprivation, and
being permanently unable to work in the multimorbidity
group (Table 1). Participants with multiple conditions
typically reported more severe foot pain, and
Fig. 1 Study participant flow chart
Hendry et al. Journal of Foot and Ankle Research           (2019) 12:36 Page 4 of 12
proportionally more foot pain affecting the hindfoot,
toes, arch, and/or nails regions of the foot (Table 3).
Closed versus open demographic and clinical
characteristics
Baseline comparisons of demographic and clinical charac-
teristics between the closed versus open cohort suggest
cohorts were similar in terms of age, sex, BMI, HRQoL and
employment status (Additional file 1). The closed cohort
participants reported lower rates of social deprivation.
Treatments received between baseline and follow-up
Treatments received over the 6-month study period are
summarised in Table 4. A median (IQR) of 2 (2–3) treat-
ments were received per patient and these most fre-
quently involved foot orthoses (47.8%), exercises (40.8%),
footwear advice/modifications (34.8%), medications
(27.8%), rest (26.1%), physical therapies (20.0%) and/or
self-management (19.1%).
Foot health differences between comorbidity groups
Between group comparisons for foot health at discrete
time points (baseline, 3 and 6month follow-ups) are pre-
sented in Table 5 and Fig. 2. The multimorbidity group ex-
hibited worse foot health scores for each domain at each
discrete time point. The single conditions group had
worse FHSQ foot pain and FHSQ foot health outcomes at
6months, but was similar to the no conditions group for
FHSQ footwear and FHSQ foot function. Statistically sig-
nificant differences were observed between groups for
FHSQ foot function at baseline, and 3 and 6month
follow-ups, with the multimorbidity group having signifi-
cantly worse foot function than the no conditions and sin-
gle conditions groups (all p < 0.01). At 6months, FHSQ
pain scores were significantly worse in the multimorbidity
versus no conditions group (p < 0.01), and FHSQ footwear
scores were significantly worse in the multimorbidity ver-
sus single conditions group (p < 0.01). Statistically signifi-
cant differences were observed between groups for FHSQ
general foot health at baseline, 3 months and 6months,
with the multimorbidity group having significantly worse
scores than the no conditions (p < 0.01) and single condi-
tions group (p < 0.05) at baseline, and the no conditions
group at 3 and 6months (both p < 0.05).
Between group changes scores are presented in Table 6.
There were no significant differences between groups for
change scores for any FHSQ domains between 0 and 3 or
0–6months (all p > 0.05). Modest improvements in FHSQ
pain were observed for each group between 0 and 3 and
0–6months. Modest improvements in FHSQ function
were observed for no conditions and single condition
groups only. Median scores of 0 suggest that FHSQ gen-
eral foot health did not improve for any group. The FHSQ
Table 1 Demographics
Whole sample No condition Single condition > 1 Condition
Number of participants, n (%) 115 (100) 26 (22.6) 28 (24.3) 61 (53)
Age in years, mean (SD) 55 (11.56) 53.4 (9.5) 52.4 (12.8) 56.95 (11.6)
BMI, median (IQR) 29.9 (19.2) 28.8 (19.7) 27.7 (21.6) 32.9 (17.8)†
Sex ratio (female:male) 68:45 17:9 14:13 37:23
EQ-5D-5 L Index, mean (SD) 0.55 (0.31) 0.73 (0.18) 0.69 (0.17) 0.42 (0.34) ‡‡
EQ-5D-5 L VAS, mean (SD) 66.69 (25.74) 78.62 (18.72) 75.3 (22.05) 57.8 (26.75) ‡‡
SIMD lowest 2 quintiles, n (%) 48 (41.7) 12 (46.2) 7 (25) 29 (47.5)
Employment status, n (%)
Paid or self-employed full time 39 (33.9) 11 (42.3) 14 (50) 14 (23.0)
Paid or self-employed part time 17 (14.8) 4 (15.4) 4 (14.3) 9 (14.8)
Voluntary work 1 (0.9) 1 (3.8) 0 1 (1.6)
Looking for work 2 (1.7) 7 (26.9) 0 2 (3.3)
Student in further or higher education 2 (1.7) 1 (3.8) 2 (7.1) 0
Looking after the home or family 4 (3.5) 1 (3.8) 1 (3.6) 2 (3.3)
Wholly retired 30 (26.1) 7 (26.9) 6 (21.4) 17 (27.9)
Permanently unable to work 10 (8.7) 1 (3.8) 0 9 (14.8)
Other 5 (4.3) 1 (3.8) 0 4 (6.6)
Prefer not to answer 2 (1.7) 0 0 2 (3.3)
Mann-Whitney tests significant at ‡‡p < 0.01 for Single Condition versus > 1 conditions group comparison
Mann-Whitney tests significant at †p < 0.05 for No conditions versus > 1 conditions comparison
SD Standard deviation, IQR Interquartile range, BMI Body mass index, SIMD Scottish Index of Multiple Deprivation, n number of participants, EQ-5D-5 L EuroQoL 5
Dimensions 5 level questionnaire, VAS Visual analogue scale
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footwear domain scores improved between 0 and 6
months for the single condition group only.
Multivariate associations between morbidity group and
FHSQ outcomes
In unadjusted analyses, multimorbidity was significantly
associated with lower (poorer) scores for FHSQ pain
(p < 0.01), function (p < 0.01) and general health (p <
0.04) at 3 and 6month follow ups (Table 7). In analyses
with adjustment for baseline corresponding FHSQ
domain score, age, BMI and sex, multimorbidity was sig-
nificantly independently associated with lower (poorer)
scores for FHSQ function (p = 0.01) at 3 months, and
FHSQ pain (p = 0.02) and FHSQ function (p < 0.01) at 6
months (Table 7).
Perception of change in foot pain group comparisons
Group comparisons for PRCS scores between 0 and 3
and 0–6 months are presented in Table 8 Proportionally,
more participants in the multimorbidity group reported
Table 3 Baseline foot pain characteristics
Whole sample (n = 115) No condition (n = 26) Single condition (n = 28) > 1 condition (n = 61)
Foot pain NRS 0–10, median (IQR) 6 (4) 5 (2.25) 6 (2.75) 8 (4)
Foot pain region, n (%)
Hindfoot 50 (43.5) 8 (30.8) 5 (17.9) 37 (60.7)
Forefoot 61 (53.0) 15 (57.7) 11 (39.3) 35 (57.4)
Toes 59 (51.3) 9 (34.6) 14 (50.0) 36 (59.0)
Ball 56 (51.3) 12 (46.2) 14 (50) 30 (49.2)
Arch 55 (47.8) 9 (34.6) 9 (32.1) 37 (60.7)
Heel 49 (42.6) 13 (50.0) 6 (21.4) 30 (49.2)
Nails 12 (10.4) 1 (3.8) 1 (3.6) 10 (16.4)
NRS Numerical rating scale, IQR Interquartile range, n number of participants
Table 2 Comorbidities
Condition, n (%) Diagnosed with condition Receiving treatment for condition Condition limits activities
Heart disease 12 (10.4) 10 (8.7) 6 (5.2)
High blood pressure 23 (20) 18 (15.7) 6 (5.2)
Lung disease 11 (9.6) 8 (7.0) 4 (3.5)
Diabetes 7 (6.1) 4 (3.5) 3 (2.6)
Ulcer/stomach disease 13 (11.3) 11 (9.6) 6 (5.2)
Kidney disease 3 (2.6) 1 (0.9) 2 (1.7)
Liver disease 3 (2.6) 1 (0.9) 1 (0.9)
Anaemia or other blood disease 10 (8.7) 6 (5.2) 6 (5.2)
Cancer 6 (5.2) 2 (1.7) 2 (1.7)
Depression 20 (17.4) 11 (9.6) 15 (13.0)
Osteoarthritis or degenerative arthritis 38 (33.0) 24 (20.9) 32 (27.8)
Back Pain 50 (43.5) 22 (19.1) 34 (29.6)
Rheumatoid or inflammatory arthritis 9 (7.8) 5 (4.3) 6 (5.2)
Other medical problems 44 (38.3) – –
Rheumatic or musculoskeletal diseasesa 7 (6.1) – –
Neurological conditionsb 9 (7.9) – –
Hypo/hyper thyroidism 5 (4.4) – –
Asthma 4 (3.5) – –
Sleep apnoea 3 (2.6) – –
Other 16 (13.9) – –
agout, mixed connective tissue disease, Sjogren’s syndrome, ankylosing spondylitis, fibromyalgia, osteopenia, and benign hypermobility (all n = 1)
bstroke/transient ischaemic attack (n = 3), trigeminal neuralgia, multiple sclerosis, Parkinson’s disease, epilepsy, polio, and neuropathy (all n = 1)
N Number of participants
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their foot pain had either deteriorated or had not chan-
ged between 0 and 3 and 0–6 months. Proportionally,
more participants in the no conditions group reported
that their foot pain had improved between 0 and 3 and
0–6 months. Group membership was significantly asso-
ciated with the perception of change in foot pain be-
tween 0 and 3 (X2 (2), 6.61, p = 0.037, medium effect
size) and 0–6 months (X2 (2), 6.90, p = 0.032, medium-
to-large effect size).
Sensitivity analyses
Closed versus open cohort sensitivity analyses are pre-
sented in Additional files 2, 3, 4, 5 and 6. Foot health
data at discrete time points was similar between closed
and open cohorts, with the multimorbidity group having
lower median FHSQ domain scores at each time point.
Some subtle differences were observed for the closed co-
hort for no conditions versus single condition groups,
where the single condition group had better scores for
some foot health domains including FHSQ pain, FHSQ
function and FHSQ footwear at baseline, and FHSQ gen-
eral foot health at 3 months. Closed cohort inferential
statistical results were largely consistent with open co-
hort analyses with the exception of FHSQ pain at 3
months (significantly poorer in multimorbidity group
versus no condition, p < 0.05), FHSQ pain at 6 months
(no statistically significant difference), and FHSQ general
foot health at baseline (no statistically significant differ-
ence). Analyses of change scores were consistent be-
tween closed and open cohorts with the exception of
FHSQ footwear, which was significantly worse in the
multimorbidity group versus no conditions group for the
closed cohort. In spite of similarly high proportions of
multimorbidity group reporting no improvement relative
to no conditions and single condition groups within the
closed cohort, associations between group membership
and perceptions of change in foot pain were not statisti-
cally significant.
Discussion
The results of this study demonstrate that people with
multimorbidity had significantly poorer foot health for
each domain of the FHSQ than people without, both be-
fore and after podiatric intervention. When adjusted for
corresponding baseline domain FHSQ score, age and
BMI, multimorbidity was independently associated with
worse FHSQ outcomes for foot function at 3 months,
and foot pain, foot function and footwear at 6 months.
The multimorbidity group did not differ significantly
Table 5 Group comparisons for FHSQ domains at baseline, 3 and 6 month follow-ups
FHSQpain, median (IQR) FHSQfunction, median (IQR) FHSQfootwear, median (IQR) FHSQhealth, median (IQR)
Baseline
No condition 41.88 (43.13) 62.5 (40.63)** 41.67 (39.58) 33.75 (38.13)**
Single condition 41.25 (41.25) 65.63 (31.25)**‡‡ 37.5 (41.67) 36.25 (44.38)**‡
> 1 conditions 29.38 (48.75) 31.25 (53.13)**†† 25.0 (39.58) 25.0 (42.5)**††
3 months
No condition 60.63 (39.69) 84.38 (28.13)** 29.17 (31.25) 42.5 (53.75)*
Single condition 47.5 (46.25) 87.5 (31.25)**‡‡ 41.67 (58.33) 60.0 (35.0)*
> 1 conditions 35.0 (43.13) 46.88 (64.06)**†† 25.0 (54.17) 25.0 (60.0)*†
6 months
No condition 69.38 (26.09)* 90.63 (21.88)** 37.5 (52.08)* 60.0 (66.25)*
Single condition 44.69 (48.91)* 87.5 (31.25)**‡‡ 41.67 (50.0)* ‡‡ 42.5 (60.0)*
> 1 conditions 35.63 (48.91)*†† 50.0 (59.38)**†† 25.0 (45.83)* 25.0 (51.25)*†
Kruskall-Wallis tests significant at **p < 0.01 and *p < 0.05
Post-hoc Mann-Whitney tests significant at ‡‡p < 0.01 and ‡p < 0.05 for Single Condition versus > 1 conditions group comparison
Post-hoc Mann-Whitney tests significant at ††p < 0.01 and †p < 0.05 for No conditions versus > 1 conditions comparison
FHSQ Foot health status questionnaire, IQR Interquartile range
Table 4 Podiatry treatments received over previous 6 months
Podiatry treatments received
over previous 6 months
Number of
participants n (%)
Foot orthoses 55 (47.83)








Number of treatments received
per patient (median, IQR)
2 (2–3)
aReferral (n = 5), steroid injection (n = 3), rocker boot, nail care, trans-electrical
nerve stimulation, dome pad
N Number of participants, IQR Interquartile range
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from comparator groups for FHSQ domain change scores
following intervention. Only modest improvements were
observed for each group for the foot pain domain, with
improvements in foot function observed in the no condi-
tions and single conditions groups only. These improve-
ments generally approached published minimal important
difference (MID) values for the FHSQ [25]. However, rela-
tive to the comparator groups the multimorbidity group
typically perceived that their foot pain did not improve
following exposure to podiatric foot care. This may be ex-
plained in part by participants in the multimorbidity
group having poorer foot health at baseline, and
remaining in states of relatively poorer foot health at 3
and 6month follow-ups in spite of similar magnitudes of
improvement in foot pain. Alternatively, it is possible that
people with multimorbidity are less able to perceive mod-
est improvements in their foot health in the context of ex-
periencing other unpleasant symptoms driven by their co-
occurring conditions. If the latter assumption is accurate,
it is likely that larger differences in FHSQ domains may be
required to achieve a difference that is perceived as benefi-
cial in this population.
There are several potential explanations for the persist-
ent poor foot health observed in the multimorbidity
group. Whilst we acknowledge that evaluation impact of
specific patterns or clusters of multimorbidity on foot
health were outwith the scope of the current study, we
can tentatively deduce that multimorbidity may have
Table 6 Group comparisons for change scores for FHSQ domains between baseline and 3months and baseline and 6month follow-ups
FHSQ pain, median (IQR) FHSQ function, median (IQR) FHSQ footwear, median (IQR) FHSQ health, median (IQR)
0 to 3 months
No condition −6.26 (35.94) − 6.23 (21.88) 0 (22.91) 0 (9.38)
Single condition −5.63 (16.88) −6.23 (21.88) 0 (25.0) 0 (21.25)
>1 conditions −6.26 (13.76) 0 (18.75) 0 (33.33) 0 (12.5)
0 to 6 months
No condition −11.88 (45.0) −18.75 (40.63) 0 (43.75) 0 (31.25)
Single condition −1.57 (41.10) −9.38 (25.0) −8.33 (25.0) 0 (37.5)
>1 conditions −6.26 (22.81) 0 (12.5) 0 (25.0) 0 (18.75)
No significant differences between groups for changes scores, Kruskall-Wallis tests
FHSQ Foot health status questionnaire, IQR Interquartile range
Fig. 2 Median fhsq scores for comorbidity groups at 0, 3 and 6 months
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involved the most prevalent and limiting conditions re-
ported namely depression, osteoarthritis and back pain.
These conditions have been identified previously as corre-
lates of foot pain [2, 26, 27] and are notoriously chronic,
persistent and difficult to manage effectively. However nu-
merous combinations of medical comorbidities were ob-
served in this population (Table 2) and further research is
required to fully understand the impact of specific multi-
morbidity clusters and foot health. Moreover, the
coexistence of mental health disorders and other function-
ally limiting conditions, known as mental-physical multi-
morbidity, has been recently recognised as a major
challenge for health care providers [4]. There may be a bi-
directional relationship between mental health and painful
physical disorders where painful symptoms can trigger
poor mental health episodes and vice-versa. In addition,
physical and mental health care is generally not delivered
in tandem [4], in spite of recent efforts to add behavioural
Table 8 Contingency tables for associations between multimorbidity group membership and PRCS improvement versus no change/
deterioration
No change/ deteriorated Improved Cramer’s V p-value
0 to 3 months (n = 94)
No condition 7 (35.0) 13 (65.0) 0.265 0.037*
Single condition 11 (50.0) 11 (50.0) – –
Multimorbidity 35 (67.3) 17 (32.7) – –
0 to 6 months (n = 82)
No condition 4 (28.6) 10 (71.4) 0.29 0.032*
Single condition 11 (47.8) 12 (52.2) – –
Multimorbidity 30 (66.7) 15 (33.3) – –
N Number of participants
Table 7 Associations between multimorbidity and FHSQ pain and function domains
Variable FHSQ pain 3 months FHSQ pain 6 months
Unadjusted B (95% confidence interval) SE B β B SE B β
Multimorbidity −17.95 (−32.92, − 2.99) 7.53 − 0.32* −25.95 (− 41.68, − 10.23) 7.90 −0.48**
Single condition − 11.13 (− 28.66, 6.40) 8.82 − 0.17 − 18.20 (− 35.72,-0.68) 8.80 − 0.30*
Adjusted
Multimorbidity −2.64 (− 13.98, 8.71) 5.70 − 0.05 − 17.17 (− 31.02, − 3.31) 6.94 − 0.32*
Single condition −3.35 (− 16.14, 9.45) 6.42 − 0.05 − 13.61 (− 28.72, 1.16) 7.40 −0.23
Baseline FHSQ pain 0.85 (0.67, 1.04) 0.09 0.77** 0.63 (0.44, 0.83) 0.10 0.60**
Age − 0.35 (− 0.76, 0.06) 0.21 −0.14 − 0.14 (− 0.57, 0.30) 0.22 −0.06
BMI 0.13 (−0.23, 0.49) 0.18 0.06 −0.01 (− 0.43, 0.41) 0.21 − 0.01
Sex − 0.11 (− 9.5, 9.30) 4.72 − 0.00 −1.88 (− 12.57, 8.82) 5.40 − 0.03
FHSQ function 3 months FHSQ function 6 months
Unadjusted B (95% confidence interval) SE B β B SE B β
Multimorbidity −33.63 8.11 −0.51** −35.36 8.67 −0.55**
Single condition −5.36 9.48 −0.07 − 5.07 9.68 −0.07
Adjusted
Multimorbidity −16.70 (−29.72, −3.67) 6.54 −0.25* −21.71 (−34.02, −9.39) 6.17 − 0.34**
Single condition −8.60 (− 22.34, 5.15) 6.90 − 0.11 −10.84 (−23.93, 2.26) 6.56 − 0.16
Baseline FHSQ function 0.75 (− 0.28, 0.58) 0.08 0.71** 0.73 (0.58, 0.88) 0.07 0.71**
Age 0.15 (−0.28, 0.58) 0.22 0.05 −0.16 (− 0.55, 0.22) 0.19 − 0.06
BMI 0.03 (−0.35, 0.41) 0.19 0.01 −0.07 (− 0.43, 0.28) 0.18 − 0.03
Sex 3.98 (−5.86, 13.81) 4.94 0.06 3.98 (−5.29, 13.22) 4.64 0.86
FHSQ Pain 3 months, R2 = 0.06 for unadjusted, R2 = 0.56 for adjusted; FHSQ Pain 6 months, R2 = 0.12 for unadjusted, R2 = 0.46 for adjusted
FHSQ Function 3 months, R2 = 0.22 for unadjusted, R2 = 0.65 for adjusted; FHSQ Function 6 months, R2 = 0.25 for unadjusted, R2 = 0.69 for adjusted
Significant at **p < 0.01 and *p < 0.05
FHSQ Foot health status questionnaire, B Beta coefficient, SE β Coefficient standard error, β Standardised beta coefficient
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components such as brief cognitive behavioural therapy
and motivational interviewing to GP [28] and Allied
Health Professional-delivered interventions [29, 30].
Healthcare inequalities have been identified in the pri-
mary care management of patients with multimorbidity
that include insufficient appointment times, higher stress
levels amongst general practitioners (GP), and lower
levels of patient enablement; defined as their ability to
cope with and self-manage their conditions [31]. To ad-
dress these inequalities, a GP-led intervention comprised
of longer appointment times and practitioner continuity;
practitioner training in holistic assessments, empathy
and self-management; and patient self-management sup-
port materials was evaluated in deprived areas of Glas-
gow, and found to be feasible and beneficial in
improving quality of life [32–34]. Whilst learning tools
to foster empathic, person-centred communication have
been piloted in podiatry settings recently [32], standard
MSK podiatric foot care largely conforms to a single-
disease model which involves management of the pre-
senting foot complaint with the possible addition of
sign-posting to lifestyle management resources for
health risk factors such as smoking.
The importance of self-management has been
highlighted recently as a key strategy for meeting the
needs of people living with multiple long-term condi-
tions [35]. The goals of self-management are to limit the
need for further disease progression and avoid the need
for more care and thus healthcare utilisation [35]. The
reduced ability of patients with multimorbidity to self-
manage their own conditions has been highlighted as a
major barrier to improved health in this population [35].
Fewer than 20% of the overall sample in the current
study reported that they attempted self-management of
their foot problem between baseline and 6-month
follow-up. It is unclear whether or not this was driven
by the negative impact of multimorbidity, or lack of pro-
motion of self-management techniques by the podiatrists
responsible for delivering foot care. Nevertheless, this
suggests that more emphasis should be placed on the
development and evaluation of holistic foot and general
health self-management strategies in podiatry settings.
Podiatric treatments provided over the course of the
study period most frequently involved provision of foot
orthoses, footwear advice and exercises, which are
largely consistent with a priori expectations of United
Kingdom (UK) NHS MSK podiatry services. The results
of this study raise questions concerning whether or not
sufficient foot health benefits can be achieved in people
who suffer from multimorbidity via interventions de-
signed to address presenting foot pain complaints in iso-
lation. The range of medical conditions observed in this
study suggest that significant proportions of patients at-
tending podiatric biomechanics services present with
complex medical problems and poor general and foot
health. Primary focus on foot and ankle biomechanics
without consideration of other aspects of holistic man-
agement such as promotion of self-management tech-
niques for broader health concerns may at least in part
explain the poor outcomes observed. However cautious
interpretation is warranted as details of treatments re-
ceived were self-reported by participants as opposed to
clinician-report or case note review which may have
been more accurate. Nevertheless, recent primary care
research has identified educational needs amongst GPs
working with multimorbid patients including: - how to
address low patient engagement with their health care
and low health literacy [31]. As such, there may be im-
portant training needs for health professionals working
in MSK services that are required to improve confidence
and competence in facilitating the holistic management
of MSK foot pain patients who have multimorbidity.
There are some limitations to this study that warrant
further attention. Whilst the overall sample size was suf-
ficient, the initial response rate to study invitations was
lower than anticipated and as such cautious interpret-
ation is warranted due to potential non-response bias.
The implications of this are that those who responded
(and those who were eligible and were subsequently en-
rolled) are not necessarily representative of the invited
population who were eligible. It is acknowledged that
not all of the 1329 patients invited would have been eli-
gible to participate. Of those who were eligible, the re-
cruitment rate was high at 74.7%. Whilst attrition rates
were generally acceptable at less than 20% at each
follow-up, some participant data sets were subject to
sporadic missing data. However, loss to follow-up and
missing data were accounted for collectively via 3 separ-
ate analysis techniques which suggested only modest dif-
ferences between closed (full data) and open cohorts
(incomplete data) and thus selection bias was concluded
to be minimal. Another strength of this study was that
participants were recruited from the routine NHS Podi-
atric Biomechanics setting by an NHS-employed podia-
trist outwith the study team, and as such vulnerability to
recruitment bias was minimised. Data were obtained
from the NHS GG&C Health Board Region and we ac-
knowledge that the socioeconomic composition of this
region differs to that of the rest of Scotland and the UK,
with higher levels of deprivation, poor health behaviours,
and lower life expectancy [36–38]. This may limit our
ability to generalise these findings to other health board
regions in the UK. We adopted a standard definition of
multimorbidity for the purposes of this study [20]. How-
ever, we acknowledge that other definitions of multimor-
bidity have been adopted in the literature and
heterogeneous methodological criteria make compari-
sons difficult [11]. In addition, morbidity groups were
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allocated according to participant’s responses to the SCQ
which is subject to some contradictory findings concern-
ing its construct validity in certain conditions. The SCQ
has been found to be accurate relative to medical notes
for the majority of its items, but performs less well for
self-reported comorbidities in people with rheumatic and
musculoskeletal conditions such as systemic sclerosis, sys-
temic lupus erythematosus [39], and ankylosing spondyl-
itis [40]. However, this limitation is largely concerned with
the construct validity of the overall SCQ comorbidity
score which was not used in our analyses.
Conclusions
Multimorbidity was associated with poor foot health and
impacts negatively on foot health outcomes following po-
diatric intervention in a sample of patients attending podi-
atric biomechanics clinics for a new episode of foot pain.
Multimorbidity was independently associated with poorer
foot pain and foot function outcomes. Multimorbidity was
also associated with lower rates of perceived improvement
in foot pain following podiatric intervention. Current
MSK foot care may be suboptimal and there are likely im-
portant training needs for podiatrists working with multi-
morbid patients. Further research is required to confirm
associations between multimorbidity and poor foot health.
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